These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 11798188)
1. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator. Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188 [TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human. Itoh H; Kataoka H; Hamasuna R; Kitamura N; Koono M Biochem Biophys Res Commun; 1999 Feb; 255(3):740-8. PubMed ID: 10049781 [TBL] [Abstract][Full Text] [Related]
3. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B. Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485 [TBL] [Abstract][Full Text] [Related]
4. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. Kirchhofer D; Peek M; Lipari MT; Billeci K; Fan B; Moran P FEBS Lett; 2005 Mar; 579(9):1945-50. PubMed ID: 15792801 [TBL] [Abstract][Full Text] [Related]
5. Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2)-related small peptide (H2RSP): its nuclear localization and generation of chimeric mRNA transcribed from both HAI-2 and H2RSP genes. Itoh H; Kataoka H; Yamauchi M; Naganuma S; Akiyama Y; Nuki Y; Shimomura T; Miyazawa K; Kitamura N; Koono M Biochem Biophys Res Commun; 2001 Oct; 288(2):390-9. PubMed ID: 11606055 [TBL] [Abstract][Full Text] [Related]
6. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039 [TBL] [Abstract][Full Text] [Related]
7. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2. Qin L; Denda K; Shimomura T; Kawaguchi T; Kitamura N FEBS Lett; 1998 Sep; 436(1):111-4. PubMed ID: 9771903 [TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Parr C; Jiang WG Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597 [TBL] [Abstract][Full Text] [Related]
9. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. Denda K; Shimomura T; Kawaguchi T; Miyazawa K; Kitamura N J Biol Chem; 2002 Apr; 277(16):14053-9. PubMed ID: 11805118 [TBL] [Abstract][Full Text] [Related]
10. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease. Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801 [TBL] [Abstract][Full Text] [Related]
12. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor. Hashimoto T; Kato M; Shimomura T; Kitamura N FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675 [TBL] [Abstract][Full Text] [Related]
13. White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues. Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Shimomura T Exp Neurol; 1998 Sep; 153(1):60-4. PubMed ID: 9743567 [TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma. Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800 [TBL] [Abstract][Full Text] [Related]
15. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. Kojima K; Tsuzuki S; Fushiki T; Inouye K J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349 [TBL] [Abstract][Full Text] [Related]
16. Changes in plasma levels of hepatocyte growth factor and its associated factors during pregnancy. Watanabe T; Sakata Y; Matsubara S; Yamagishi T; Nagaike K; Kuwata T; Suzuki M J Obstet Gynaecol Res; 2006 Feb; 32(1):10-4. PubMed ID: 16445520 [TBL] [Abstract][Full Text] [Related]
17. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. Kawaguchi T; Qin L; Shimomura T; Kondo J; Matsumoto K; Denda K; Kitamura N J Biol Chem; 1997 Oct; 272(44):27558-64. PubMed ID: 9346890 [TBL] [Abstract][Full Text] [Related]
18. Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Kaido T; Oe H; Yoshikawa A; Okajima A; Imamura M Hepatogastroenterology; 2004; 51(56):547-51. PubMed ID: 15086199 [TBL] [Abstract][Full Text] [Related]